Anti-angiogenic vaccines as a treatment modality for cancer.

Curr Opin Investig Drugs

EntreMed Inc, 9640 Medical Center Drive, Rockville, MD 20850, USA.

Published: December 2004

Targeting angiogenesis to inhibit tumor development is now considered a valid approach to disease modulation. Recently, a number of laboratories have focused their research on the development of cancer vaccines that target modulators of angiogenesis. In this review we describe a number of novel vaccines that target mediators of angiogenesis and inhibit tumor progression in preclinical models.

Download full-text PDF

Source

Publication Analysis

Top Keywords

angiogenesis inhibit
8
inhibit tumor
8
vaccines target
8
anti-angiogenic vaccines
4
vaccines treatment
4
treatment modality
4
modality cancer
4
cancer targeting
4
targeting angiogenesis
4
tumor development
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!